Opioid Addiction News and Research

RSS

FDA warns consumers and pet owners not to use drug products made by King Bio

The Food and Drug Administration is warning consumers and pet owners not to use drug products, including homeopathic drug products, made by King Bio Inc., Asheville, N.C., and labeled as Dr. King's, as these products may pose a safety risk to people (especially infants, children, pregnant women and those with compromised immune systems), as well as pets due to high levels of microbial contamination identified at the manufacturing site.

29 Aug 2018

Unique pain program helps surgical patients wean off opioids safely and effectively

A unique pain program is helping complex surgical patients wean off opioids safely and effectively, while offering alternative ways to cope with their pain and improve how they function.

20 Aug 2018

Babies dependent on opioids need touch, not tech

Dr. Jodi Jackson has worked for years to address infant mortality in Kansas. Often, that means she treats newborns in a high-tech neonatal intensive care unit with sophisticated equipment whirring and beeping. And that is exactly the wrong place for an infant like Lili.

20 Aug 2018

WVU researchers examine safety of Suboxone use in opioid-dependent pregnant women

Medications that physicians have traditionally prescribed to treat opioid use disorders-such as methadone and Subutex-can be misused by taking them in larger amounts than prescribed or by injecting them.

7 Aug 2018

FSMB partners with NAM to form Action Collaborative on countering opioid epidemic

In recognition of the need for a national coordinated and collective response to the epidemic of opioid addiction in the U.S., the Federation of State Medical Boards is partnering with the National Academy of Medicine and 35 organizations to form the Action Collaborative on Countering the U.S. Opioid Epidemic.

1 Aug 2018

Routine screening, treatment could help stem nationwide opioid epidemic

To help stem the nationwide opioid epidemic and related increases in HIV, hepatitis C and other infections, health care providers should routinely screen and treat patients for opioid abuse when they come to clinics and hospitals seeking other services.

16 Jul 2018

What a U.S.-China trade war could mean for the opioid epidemic

The American struggle to curb opioid addiction could become collateral damage in President Donald Trump's showdown on trade.

6 Jul 2018

Non-opioid drug shows promise for treating pain by targeting receptors on immune cells

Faced with the epidemic of opioid addiction, researchers have been charged with finding other strategies to treat pain. Their efforts largely have focused on nerve cells that transmit pain signals to the spinal cord and brain.

6 Jul 2018

Nurses take on expanded roles to provide access to health care in rural, underserved areas

To help address access to health care for rural and underserved areas, registered nurses can take on expanded roles in primary care delivery.

4 Jul 2018

Judge blocks Kentucky Medicaid work requirement

A federal judge on Friday struck down a Trump administration decision allowing states to force low-income adults to work to qualify for Medicaid.

29 Jun 2018

CRISPR technique reduces repetitive behavior in fragile X syndrome mouse models

Scientists have used CRISPR-Cas9 gene editing to lessen some autism symptoms in mice with a form of fragile X syndrome, the most common known single-gene cause of autism spectrum disorder.

25 Jun 2018

Methadone or buprenorphine associated with reductions in opioid related mortality

A National Institutes of Health-funded study found that treatment of opioid use disorder with either methadone or buprenorphine following a nonfatal opioid overdose is associated with significant reductions in opioid related mortality.

19 Jun 2018

After opioid overdose, only 30 percent get medicine to treat addiction

More than 115 Americans die every day of opioid overdose. Many more survive thanks to the antidote medication, naloxone. But a study out Monday finds that just 3 in 10 patients revived by an EMT or in an emergency room received the follow-up medication known to avoid another life-threatening event.

19 Jun 2018

If you’ve got hep C, spitting can be a felony

Last week, an Ohio man who has the hepatitis C virus was sentenced to 18 months in prison for spitting at Cleveland police and medics.

19 Jun 2018

Researchers examine risk factors for opioid dependence in patients undergoing surgery for DS

Researchers investigated risk factors for the development of opioid dependence in patients undergoing surgery for degenerative spondylolisthesis

19 Jun 2018

Researchers explore how postoperative patients can be protected from opioid addiction

Greater coordination is needed between surgeons and physicians about the prescription of pain-relieving opioid drugs following surgery to help identify patients who are at risk of becoming opioid addicts.

13 Jun 2018

Researchers develop model that predicts changes in BUP exposure during pregnancy

Buprenorphine (BUP) is approved for the treatment of opioid addiction. The current dosing regimen of BUP in pregnant women is based on recommendations designed for non-pregnant adults, but physiological changes during pregnancy may alter BUP exposure and efficacy.

7 Jun 2018

FDA warns nine online networks to stop illegal marketing of unapproved opioids

The U.S. Food and Drug Administration today announced that it has warned nine online networks, operating a total of 53 websites, that they must stop illegally marketing potentially dangerous, unapproved and misbranded versions of opioid medications, including tramadol and oxycodone.

6 Jun 2018

In-hospital opioid prescribing may increase post-discharge opioid use, shows study

Patients who receive an opioid for most of their hospital stay and patients who are still taking an opioid within 12 hours of being discharged from the hospital appear more likely to fill a prescription for opioids within 90 days of leaving the hospital, according to new research presented at the ATS 2018 International Conference.

21 May 2018

FDA OKs first non-opioid drug for adults with opioid withdrawal symptoms

The United States Food and Drugs Administration (FDA), in a statement this week, approved a new drug Lucemyra (lofexidine hydrochloride) for the treatment and alleviation of opioid symptom withdrawal symptoms in adults in whom the drugs have been withdrawn abruptly.

17 May 2018

Opioid Addiction News and Research

FDA warns consumers and pet owners not to use drug products made by King Bio

Unique pain program helps surgical patients wean off opioids safely and effectively

Babies dependent on opioids need touch, not tech

WVU researchers examine safety of Suboxone use in opioid-dependent pregnant women

FSMB partners with NAM to form Action Collaborative on countering opioid epidemic

Routine screening, treatment could help stem nationwide opioid epidemic

What a U.S.-China trade war could mean for the opioid epidemic

Non-opioid drug shows promise for treating pain by targeting receptors on immune cells

Nurses take on expanded roles to provide access to health care in rural, underserved areas

Judge blocks Kentucky Medicaid work requirement

CRISPR technique reduces repetitive behavior in fragile X syndrome mouse models

Methadone or buprenorphine associated with reductions in opioid related mortality

After opioid overdose, only 30 percent get medicine to treat addiction

If you’ve got hep C, spitting can be a felony

Researchers examine risk factors for opioid dependence in patients undergoing surgery for DS

Researchers explore how postoperative patients can be protected from opioid addiction

Researchers develop model that predicts changes in BUP exposure during pregnancy

FDA warns nine online networks to stop illegal marketing of unapproved opioids

In-hospital opioid prescribing may increase post-discharge opioid use, shows study

FDA OKs first non-opioid drug for adults with opioid withdrawal symptoms

Event guide: The Non-Opioid Pain Therapeutics Summit eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News